Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB

Free Radical Biology and Medicine

Volumn 28, Issue 9, 2000, Pages 1317-1327

  Janssen Heininger, Yvonne M W ^a,c   Poynter, Matthew E ^a   Baeuerle, Patrick A ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b MICROMET AG   (Germany)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Free radicals; Mitogen activated protein kinases; NF B; Nitrogen monoxide; Phosphoinositide 3 kinase; Protein kinase A; Redox; Signaling

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

CHEMICAL REACTION; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; SEQUENCE HOMOLOGY; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0034190367     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00218-5     Document Type: Article

References (95)

1. Flohe L., Brigelius-Flohe R., Saliou C., Traber M.G., Packer L. Redox regulation of NF-κB activation. Free Radic. Biol. Med. 22:1997;1115-1126.
2. Ginn-Pease M.E., Whisler R.L. Redox signals and NF-κB activation in T cells. Free Radic. Biol. Med. 25:1998;346-361.
3. Baeuerle P.A. IκB-NF-κB structures at the interface of inflammation control . Cell. 95:1998;729-731.
4. May M.J., Ghosh S. Signal transduction through NF-κB. Immunol. Today. 19:1998;80-88.
5. Verma I.M., Stevenson J.K., Schwarz E.M., Van Antwerp D., Miyamoto S. Rel/NF-κB/IκB family intimate tales of association and dissociation . Genes Dev. 9:1995;2723-2735.
6. Baeuerle P.A., Baltimore D. NF-κB ten years after . Cell. 87:1996;13-20.
7. Ghosh S., May M.J., Kopp E.B. NF-κB and Rel proteins evolutionarily conserved mediators of immune responses . Ann. Rev. Immunol. 16:1988;225-260.
8. Li T., Narhi L.O., Wen J., Philo J.S., Sitney K., Inoue J., Yamamoto T., Arakawa T. Interactions between NF-κB and its inhibitor IκB biophysical characterization of a NF-κB/IκB-alpha complex . J. Protein Chem. 17:1998;757-763.
9. Simeonidis S., Stauber D., Chen G., Hendrickson W.A., Thanos D. Mechanisms by which IκB proteins control NF-κB activity. Proc. Natl. Acad. Sci. USA. 96:1999;49-54.
10. Huxford T., Huang D.B., Malek S., Ghosh G. The crystal structure of the IκBα/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell. 95:1998;759-770.
11. Jacobs M.D., Harrison S.C. Structure of an IκB-α/NF-κB complex. Cell. 95:1998;749-758.
12. Baeuerle P.A. IκB-NF-κB structures at the interface of inflammation control . Cell. 95:1998;729-731.
13. Cramer P., Muller C.W. A firm hand on NF-κB structures of the IκB-α-NF-κB complex . Structure Fold Des. 7:1999;R1-R6.
14. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., Baldwin A.S. Jr. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19:1999;5785-5799.
15. Pahl H.L. Signal transduction from the endoplasmic reticulum to the cell nucleus. Physiol. Rev. 79:1999;683-701.
16. Tamatani M., Che Y.H., Matsuzaki H., Ogawa S., Okado H., Miyake S., Mizuno T., Tohyama M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NF-κB activation in primary hippocampal neurons. J. Biol. Chem. 274:1999;8531-8538.
17. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. Jr. NF-κB antiapoptosis induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress capspase-8 activation . Science. 281:1998;1680-1683.
18. Manna S.K., Zhang H.J., Yan T., Oberley L.W., Aggarwal B.B. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor κB and activated protein 1. J. Biol. Chem. 273:1998;13245-13254.
19. LeBail O., Schmidt-Ullrich R., Israel A. Promoter analysis of the gene encoding the IκB-α/MAD3 inhibitor of NF-κB positive regulation by members of the rel/NF-κB family . EMBO J. 12:1993;5043-5049.
20. Arenzana-Seisdedos, F.; Turpin, P.; Rodriguez, M.; Thomas, D.; Hay, R. T.; Virelizier, J. L.; Dargemont, C. Nuclear localization of IκB-α promotes active transport of NF-κB from the nucleus to the cytoplasm. J. Cell Sci. 1120:369-378.
21. Harhaj E.W., Sun S.C. Regulation of RelA subcellular localization by a putative nuclear export signal and p50. Mol. Cell. Biol. 19:1999;7088-7095.
22. Suyang H., Phillips R., Douglas I., Ghosh S. Role of unphosphorylated, newly synthesized IκB-β in persistent activation of NF-κB. Mol. Cell. Biol. 16:1996;5444-5449.
23. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature. 388:1997;548-554.
24. Regnier C.H., Song H.Y., Gao X., Goeddel D.V., Cao Z., Rothe M. Identification and characterization of an IκB kinase. Cell. 90:1997;373-383.
25. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell. 91:1997;243-252.
26. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J.W., Young D.B., Barbosa M., Mann M. IKK-1 and IKK-2 cytokine-activated IκB kinases essential for NF-κB activation . Science. 278:1997;860-866.
27. Woronicz J.D., Gao X., Cao Z., Rothe M., Goeddel D.V. IκB kinase-β NF-κB activation and complex formation with IκB kinase-α and NIK . Science. 278:1997;866-869.
28. Maniatis T. Catalysis by a multiprotein IκB kinase complex. Science. 278:1997;818-819.
29. Zandi E., Karin M. Bridging the gap composition, regulation, and physiological function of the IκB kinase complex . Mol. Cell Biol. 19:1999;4547-4551.
30. Muzio M., Ni J., Feng P., Dixit V.M. IRAK (Pelle) family member IRAK-2 and Myd88 as proximal mediators of Il-1 signaling. Science. 278:1997;1612-1615.
31. Lee F.S., Hagler J., Chen Z.J., Maniatis T. Activation of the IκB-α kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 88:1997;213-222.
32. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., Israel A. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell. 93:1998;1231-1240.
33. Cohen L., Henzel W.J., Bauerle P.A. IκAP is a scaffold protein of the IκB kinase complex. Nature. 395:1998;292-296.
34. Li Q., Van Antwerp D., Mercurio F., Lee K.F., Verma I.M. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science. 284:1999;321-325.
35. Beg A.A., Sha W.K., Bronson R.T., Ghosh S., Baltimore D. Embryonic lethality in mice lacking the RelA component of NF-κB. Nature. 376:1995;167-170.
36. Hu Y., Baud V., Delhase M., Zhang P., Deerinck T., Ellisman M., Johnson R., Karin M. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science. 284:1999;316-320.
37. Karin M., Delhase M. JNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action? Proc. Natl. Acad. Sci. USA. 95:1998;9067-9069.
38. Li N., Karin M. Ionizing radiation and short wavelength UV activate NF-κB through two disinct mechanisms. Proc. Natl. Acad. Sci. USA. 95:1998;13012-13017.
39. Bender K., Gottlicher M., Whiteside S., Rahmsdorf H.J., Herrlich P. Sequential DNA damage-independent and -dependent activation of NF-κB by UV. EMBO J. 17:1998;5170-5181.
40. Barroga C.F., Stevenson J.K., Schwarz E.M., Verma I.M. Constitutive phosphorylation of IκB-α by casein kinase II. Proc. Natl. Acad. Sci. USA. 92:1995;7637-7641.
41. Czu Z.L., McKinsey T.A., Liu L., Qi X., Ballard D.W. Basal phosphorylation of the PEST domain in the IκB-β regulates its functional interaction with the c-rel proto-oncogene product. Mol. Cell. Biol. 16:1996;5974-5984.
42. Imbert V., Rupec R.A., Livolsi A., Pahl H.L., Traenckner B.M., Mueller-Dieckmann C., Farahifar D., Rossi B., Auberger P., Baeuerle P.A., Peyron J.F. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α Cell. 86:1996;787-798.
43. Beraud C., Henzel W.J., Baeuerle P.A. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation. Proc. Natl. Acad. Sci. USA. 96:1999;429-434.
44. Israel N., Gougerot-Pocidalo M.A., Aillet F., Virelizier J.L. Redox status of cells influences constitutive or induced NF-κB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J. Immunol. 149:1992;3386-3393.
45. Ginn-Pease M.E., Whisler R.L. Optimal NF-κB-mediated transcriptional responses in Jurkat T cells exposed to oxidative stress are dependent on intracellular glutathione and costimulatory signals. Biochem. Biophys. Res. Comm. 226:1996;695-702.
46. Janssen-Heininger Y.M.W., Macara I., Mossman B.T. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-κB requirement of Ras/mitogen-activated protein kinases in the activation of NF-κB by oxidants . Am. J. Respir. Cell Mol. Biol. 20:1999;942-952.
47. Singh S., Darnay B.G., Aggarwal B.B. Site-specific tyrosiine phosphorylation of IκB-α negatively regulates its inducible phosphorylation and degradation. J. Biol. Chem. 271:1996;31049-31054.
48. Derijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., Karin M., Davis R.J. JNK1 a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain . Cell. 76:1994;1025-1037.
49. Zhong H., SuYang H., Erdjument-Bromage H., Tempst P., Ghosh S. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell. 89:1997;413-424.
50. Sizemore N., Leung S., Stark G.R. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit. Mol. Cell. Biol. 19:1999;4798-4805.
51. Wang D., Baldwin A.S. Jr. Activation of nuclear factor κB-dependent transcription by tumor necrosis factor α is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem. 273:1998;29411-29416.
52. Zhong H., Voll R.E., Ghosh S. Phosphorylation of NF-κB by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Molec. Cell. 1:1998;661-671.
53. Gerritsen M.E., Williams A.J., Neish A.S., Moore S., Shi Y., Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA. 94:1997;2927-2932.
54. Sheppard K.A., Rose D.W., Haque Z.K., Kurokawa R., McInerney E., Westin S., Thanos D., Rosenfeld M.G., Glass C.K., Collins T. Transcriptional activation by NF-κB requires multiple coactivators. Mol. Cell. Biol. 19:1999;6367-6378.
55. Karin M. Mitogen-activated protein kinase cascades as regulators of stress responses. Ann. NY Acad. Sci. 851:1998;139-146.
56. Song H.Y., Regnier C.H., Kirschning C.J., Goeddel D.V., Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades bifurcation of nuclear factor κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2 . Proc. Natl. Acad. Sci. USA. 94:1997;9792-9796.
57. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature. 385:1997;540-544.
58. Lee F.S., Peters R.T., Dang L.C., Maniatis T. MEKK1 activates both IκB kinase α and IκB kinase β Proc. Natl. Acad. Sci. USA. 95:1998;9319-9324.
59. Nemoto S., DiDonato J.A., Lin A. Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB-inducing kinase. Mol. Cell. Biol. 18:1998;7336-7343.
60. Zhao Q., Lee F.S. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activated nuclear factor κB through IκB kinase α and IκB kinase β J. Biol. Chem. 274:1999;8355-8358.
61. Rand M.A., Whitley M.Z., Gupta S., Pierce J.W., Best J., Davis R.J., Collins T. Tumor necrosis factor α-induced E-selectin expression is activated by the nuclear factor κB and c-Jun N-terminal kinase/p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 272:1997;2753-2761.
62. Da Silva J., Pierrat B., Mary J.L., Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J. Biol. Chem. 272:1997;28373-28380.
63. Chen C.C., Wang J.K. P38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipoplysaccharide in RAW 264.7 macrophages. Mol. Pharmacol. 55:1999;481-488.
64. Nick J.A., Avdi N.J., Young S.K., Lehman L.A., McDonald P.P., Frasch S., Billstrom M.A., Henson P.M., Johnson G.L., Worthen G.S. Selective activation and functional significance of p38α mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J. Clin. Invest. 103:1999;851-858.
65. Tuyt L.M., Dokter W.H., Birkenkamp K., Koopmans S.B., Lummen C., Kruijer W., Vellenga E. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-κB-dependent IL-6 expression in human monocytes. J. Immunol. 162:1999;4893-4902.
66. Kempiak S.J., Hiura T.S., Nel A.E. The Jun kinase cascade is responsible for activating the CD28 response element of the IL-2 promoter proof of cross talk with the IκB kinase cascade . J. Immunol. 162:1999;3176-3187.
67. Beyaert R., Cuenda A., Vanden Berghe W., Plaisance S., Lee J.C., Haegeman G., Cohen P., Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin 6 synthesis in response to tumour necrosis factor. EMBO J. 15:1996;1914-1923.
68. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., Haegeman G. P38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273:1998;3285-3290.
69. Wesselborg S., Bauer M.K., Vogt M., Schmitz M.L., Schulze-Osthoff K. Activation of transcription factor NF-κB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J. Biol. Chem. 272:1997;12422-12429.
70. Zechner D., Craig R., Hanford D.S., McDonough P.M., Sabbadini R.A., Glembotski C.C. MKK6 activates myocardial cell NF-κB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J. Biol. Chem. 273:1998;8232-8239.
71. Schwenger P., Alpert D., Skolnik E.Y., Vilcek J. Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IκB-α phosphorylation and degradation. Mol. Cell. Biol. 18:1998;78-84.
72. Meyer C.F., Wang X., Chang C., Templeton D., Tan T.H. Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating κB enhancer activation. J. Biol. Chem. 271:1996;8971-8976.
73. Haridas V., Ni J., Meager A., Su J., Yu G.L., Zhai Y., Kyaw H., Akama K.T., Hu J., Van Eldik L.J., Aggarwal B.B. Cutting edge TRANK, a novel cytokine that activates NF-κB and c-Jun N-terminal kinase . J. Immunol. 161:1998;1-6.
74. Kim Y.M., Bombeck C.A., Billiar T.R. Nitric oxide as a bifunctional regulator of apoptosis. Circ. Res. 84:1999;253-256.
75. Wong H.R. Nuclear factor κB and nitric oxide regulating life and death nonsense or harsh reality? Crit. Care Med. 26:1998;1470-1471.
76. Umansky V., Hehner S.P., Dumont A., Hofmann T.G., Schirrmacher V., Droge W., Schmitz M.L. Costimulatory effect of nitric oxide on endothelial NF-κB implies a physiological self-amplifying mechanism. Eur. J. Immunol. 28:1998;2276-2282.
77. Lander H.M., Jajjar D.P., Hempstead B.L., Mirza U.A., Chait T.B., Campbell S., Quilliam L.A. A molecular redox switch on p21ras structural basis for the nitric oxide-p21ras interactions . J. Biol. Chem. 272:1997;4323-4326.
78. Yun H.Y., Gonzalez-Zulueta M., Dawson V.L., Dawson T.M. Nitric oxide mediates N-methyl-D-aspartate receptor-induced activation of p21ras. Proc. Natl. Acad. Sci. USA. 95:1998;5773-5778.
79. Park S.K., Lin H.S., Murphy S. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-κB binding to DNA. Biochem. J. 322:1997;609-613.
80. Taylor B.S., Kim Y.M., Wang Q., Shapiro R.A., Billiar T.R., Geller D.A. Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch. Surg. 132:1997;1177-1183.
81. Peng H.B., Spiecker M., Liao J.K. Inducible nitric oxide an autoregulatory feedback inhibitor of vascular inflammation . J. Immunol. 161:1998;1970-1976.
82. Sekkai D., Aillet F., Israel N., Lepoivre M. Inhibition of NF-κB and HIV-1 long terminal repeat transcriptional activation by inducible nitric oxide synthase 2 activity. J. Biol. Chem. 273:1998;3895-3900.
83. Shin W.S., Hong Y.H., Peng H.B., De Caterina R., Libby P., Liao J.K. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-γ. The role of constitutive NF-κB activity. J. Biol. Chem. 271:1996;11317-11324.
84. Katsuyama K., Shichiri M., Marumo F., Hirata Y. NO inhibits cytokine-induced iNOS expression and NF-κB activation by interfering with phosphorylation and degradation of IκB-α Arterioscler. Thromb. Vasc. Biol. 18:1998;1796-1802.
85. De la Torre A., Schroeder R.A., Punzalan C., Kuo P.C. Endotoxin-mediated S-nitrosylation of p50 alters NF-κB-dependent gene transcription in ANA-1 murine macrophages. J. Immunol. 162:1999;4101-4108.
86. Griscavage J.M., Wilk S., Ignarro L.J. Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-κB. Proc. Natl. Acad. Sci. USA. 93:1996;3308-3312.
87. De la Torre A., Schroeder R.A., Kuo P.C. Alteration of NF-κB P50 DNA-binding kinetics by S-nitrosylation. Biochem. Biophys. Res. Commun. 238:1997;703-706.
88. Matthews J.R., Botting C.H., Panico M., Morris H.R., Hay R.T. Inhibition of NF-κB DNA-binding by nitric oxide. Nucl. Acids Res. 24:1996;2236-2242.
89. Walley K.R., McDonald T.E., Higashimoto Y., Hayashi S. Modulation of proinflammatory cytokines by nitric oxide in immune acute lung injury. Am. J. Respir. Crit. Care Med. 160:1999;698-704.
90. Chen F., Lu Y., Castranova V., Rejanasakul Y., Miyahara K., Shizuta Y., Vallyathan V., Shi X., Demers L.M. Nitric oxide inhibits HIV tat-induced NF-κB activation. Am. J. Pathol. 155:1999;275-284.
91. Brady T.C., Chang L.Y., Day B.J., Crapo J.D. Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-κB activation. Am. J. Physiol. 273:1997;L1002-L1006.
92. Wong G.H.W., Goedel D.V. Induction of manganous superoxide dismutase y tumor necrosis factor possible protective mechanism . Science. 242:1988;941-943.
93. Miller M.J., Sandoval M. Nitric oxide. III. A molecular prelude to intestinal inflammation. Am. J. Physiol. 276:1999;G795-G799.
94. van der Vliet A., Eiserich J.P., Shigedage M.K., Cross C.E. Reactive nitrogen species and tyrosine nitration in the respiratory tract epiphenomena or a pathobiologic mechanism of disease? Am. J. Respir. Crit. Care Med. 160:1999;109.
95. Li N., Karin M. Is NF-κB the sensor of oxidative stress? FASEB J. 13:1999;1137-1143.